Advisor Live: Understanding the Part B Drug Payment Proposed Model from CMS

July 7, 2016
The Centers for Medicare & Medicaid Services (CMS) recently issued a proposed rule establishing a new mandatory payment model for Medicare Part B drugs. CMS said the two-phase model would test whether the alternative drug payment design will lead to a reduction in Medicare spending, while preserving or enhancing the quality of care for Medicare beneficiaries. This webinar provides an overview of the proposals including: Geographic areas selected and trial design of the two-phase model Part B drug add-on payment changes starting in phase one Application of value-based purchasing tools starting in phase two Interactions with other payment policies Provider, supplier, and beneficiary protections EXPERT PRESENTER Marla Kugel, MPH, Principal Research Scientist, Premier Inc.
Previous Presentation
A Pharmacy Discussion
A Pharmacy Discussion

What does the future hold for pharmacy benefit managers (PBMs)? This webinar discusses: How to better man...

Next Presentation
Advisor Live: Optimizing Outcomes and Managing Costs - IV Acetaminophen and Liposomal Bupivacaine
Advisor Live: Optimizing Outcomes and Managing Costs - IV Acetaminophen and Liposomal Bupivacaine

Multimodal pain management is a treatment philosophy using multiple modalities to control post-operative pa...